Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin L Masters

Showing results (71-80 of 775) with videos related to

Pageof 78
Sort By:
Communicable Diseases Intelligence Quarterly Report|August 4, 2010
Surveillance of Creutzfeldt-Jakob disease in Australia: 2010 updateGenevieve M Klug, Alison Boyd, Amelia McGlade, et al.
Annals of Neurology|June 3, 2004
Increased beta-Secretase activity in cerebrospinal fluid of Alzheimer's disease subjectsR M Damian Holsinger, Catriona A McLean, Steven J Collins, et al.
Journal of Cellular and Molecular Medicine|April 21, 2009
Abeta aggregation and possible implications in Alzheimer's disease pathogenesisPrashant R Bharadwaj, Ashok K Dubey, Colin L Masters, et al.
BMJ Neurology Open|September 16, 2022
Cerebrospinal fluid sampling for research of Alzheimer's disease and other neurodegenerative diseases when lumbar punctures are performed by anaesthetistsKelly J Atkins, Lisbeth Evered, David A Scott, et al.
The Journal of Biological Chemistry|February 19, 2004
The proteolytic processing of the amyloid precursor protein gene family members APLP-1 and APLP-2 involves alpha-, beta-, gamma-, and epsilon-like cleavages: modulation of APLP-1 processing by n-glycosylationSimone Eggert, Krzysztof Paliga, Peter Soba, et al.
Annals of Neurology|September 27, 2002
Quinacrine does not prolong survival in a murine Creutzfeldt-Jakob disease modelSteven J Collins, Victoria Lewis, Marcus Brazier, et al.
Nature Reviews. Disease Primers|May 19, 2016
Alzheimer's diseaseColin L Masters, Randall Bateman, Kaj Blennow, et al.
Frontiers in Psychiatry|December 20, 2024
Using cerebrospinal fluid biomarkers to diagnose Alzheimer's disease: an Australian perspectiveDhamidhu Eratne, Steven Collins, Peter J Nestor, et al.
The Journal of Biological Chemistry|November 28, 2002
The transmembrane domain of the amyloid precursor protein in microsomal membranes is on both sides shorter than predictedBeate Grziwa, Marcus O W Grimm, Colin L Masters, et al.
Analytical and Bioanalytical Chemistry|February 8, 2020
Optimizing red blood cell protein extraction for biomarker quantitation with mass spectrometryStephan Klatt, Anne Roberts, Amber Lothian, et al.
Pageof 78

Showing results (71-80 of 775) with videos related to

Sort By:
Pageof 78
Communicable Diseases Intelligence Quarterly Report|August 4, 2010
Surveillance of Creutzfeldt-Jakob disease in Australia: 2010 updateGenevieve M Klug, Alison Boyd, Amelia McGlade, et al.
Annals of Neurology|June 3, 2004
Increased beta-Secretase activity in cerebrospinal fluid of Alzheimer's disease subjectsR M Damian Holsinger, Catriona A McLean, Steven J Collins, et al.
Journal of Cellular and Molecular Medicine|April 21, 2009
Abeta aggregation and possible implications in Alzheimer's disease pathogenesisPrashant R Bharadwaj, Ashok K Dubey, Colin L Masters, et al.
BMJ Neurology Open|September 16, 2022
Cerebrospinal fluid sampling for research of Alzheimer's disease and other neurodegenerative diseases when lumbar punctures are performed by anaesthetistsKelly J Atkins, Lisbeth Evered, David A Scott, et al.
The Journal of Biological Chemistry|February 19, 2004
The proteolytic processing of the amyloid precursor protein gene family members APLP-1 and APLP-2 involves alpha-, beta-, gamma-, and epsilon-like cleavages: modulation of APLP-1 processing by n-glycosylationSimone Eggert, Krzysztof Paliga, Peter Soba, et al.
Annals of Neurology|September 27, 2002
Quinacrine does not prolong survival in a murine Creutzfeldt-Jakob disease modelSteven J Collins, Victoria Lewis, Marcus Brazier, et al.
Nature Reviews. Disease Primers|May 19, 2016
Alzheimer's diseaseColin L Masters, Randall Bateman, Kaj Blennow, et al.
Frontiers in Psychiatry|December 20, 2024
Using cerebrospinal fluid biomarkers to diagnose Alzheimer's disease: an Australian perspectiveDhamidhu Eratne, Steven Collins, Peter J Nestor, et al.
The Journal of Biological Chemistry|November 28, 2002
The transmembrane domain of the amyloid precursor protein in microsomal membranes is on both sides shorter than predictedBeate Grziwa, Marcus O W Grimm, Colin L Masters, et al.
Analytical and Bioanalytical Chemistry|February 8, 2020
Optimizing red blood cell protein extraction for biomarker quantitation with mass spectrometryStephan Klatt, Anne Roberts, Amber Lothian, et al.
Pageof 78